A. Saeed, Faisal Majid Al-Fayyadh, Khalid M. Alshomar, Ziad Wael Zekry, N. Alamiri, A. M. Abaalkhail, Abdullah S. Aldughaither, Yasser A. Alaska
Introduction: The implementation of triage systems seeks to aid patient organisation in order to assure smooth patient flow. Inconsistency in the application of the triage system at a local university hospital has been a recent concern for the administrative faculty. Therefore, our aim was to validate the implementation of the Canadian Triage and Acuity Scale (CTAS), currently applied by nurses, in a university hospital. Materials and Methods: Patient information was collected in the Emergency Department and translated from real case scenarios into paper-based scenarios. A total of 49 cases were distributed among 45 nurses to categorise. The nurses' categorisations were compared with a CTAS expert's categorisations. Results: Of the 2,205 cases (49 cases each given to the 45 nurses), 49% (1,059 cases) were correctly categorised and 51% (1,146 cases) were miscategorised. Overtriage and undertriage percentages were 55.93% and 44.07%, respectively. The highest level of agreement between nurses and the expert categorisation was in category 1; the lowest was in category 5. Conclusion: The nurses' overall results were below expectations. Statistically significant variables affecting correct categorisation included age, experience, education level and nationality of the nurses. Nurses above the age of 45 years with more years of experience, obtained top scores. Nurses with the highest level of education also scored significantly higher. Filipino nurses scored better than nurses of other nationalities. With the widespread utilisation of triage systems in the region, further studies that evaluate their implementation are needed.
{"title":"Validating the implementation of the triage system in an emergency department in a University Hospital","authors":"A. Saeed, Faisal Majid Al-Fayyadh, Khalid M. Alshomar, Ziad Wael Zekry, N. Alamiri, A. M. Abaalkhail, Abdullah S. Aldughaither, Yasser A. Alaska","doi":"10.4103/JHS.JHS_113_16","DOIUrl":"https://doi.org/10.4103/JHS.JHS_113_16","url":null,"abstract":"Introduction: The implementation of triage systems seeks to aid patient organisation in order to assure smooth patient flow. Inconsistency in the application of the triage system at a local university hospital has been a recent concern for the administrative faculty. Therefore, our aim was to validate the implementation of the Canadian Triage and Acuity Scale (CTAS), currently applied by nurses, in a university hospital. Materials and Methods: Patient information was collected in the Emergency Department and translated from real case scenarios into paper-based scenarios. A total of 49 cases were distributed among 45 nurses to categorise. The nurses' categorisations were compared with a CTAS expert's categorisations. Results: Of the 2,205 cases (49 cases each given to the 45 nurses), 49% (1,059 cases) were correctly categorised and 51% (1,146 cases) were miscategorised. Overtriage and undertriage percentages were 55.93% and 44.07%, respectively. The highest level of agreement between nurses and the expert categorisation was in category 1; the lowest was in category 5. Conclusion: The nurses' overall results were below expectations. Statistically significant variables affecting correct categorisation included age, experience, education level and nationality of the nurses. Nurses above the age of 45 years with more years of experience, obtained top scores. Nurses with the highest level of education also scored significantly higher. Filipino nurses scored better than nurses of other nationalities. With the widespread utilisation of triage systems in the region, further studies that evaluate their implementation are needed.","PeriodicalId":31033,"journal":{"name":"Journal of Health Specialties","volume":"50 1","pages":"73 - 79"},"PeriodicalIF":0.0,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90996432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-01-01DOI: 10.4103/2468-6360.198795
A. Jamjoom
Objectives: The objective of this study was to identify the medical specialities that had a positive relative contribution to scientific productivity in the Kingdom of Saudi Arabia (KSA) over the last two decades and to determine the influence of their contribution on KSA worldwide ranking in these specialities. Methods: SCImago Journal and Country Rank was used to determine KSA's ranking in 46 medical specialities during 1996-2014 based on four productivity indices. Relative Specialisation Index (RSI) was calculated for each speciality. Specialities with RSI >0 were defined as the positive relative contribution specialities in KSA. They were compared with the remaining specialities using a number of parameters that were examined statistically. Results: The median KSA ranking in 46 specialities was 42 for total documents, 43 for total cites, 79 for citations per document and 44 for h-index. Fourteen (30%) specialities were designated as the positive relative contribution specialities in KSA. These were ophthalmology, medicine (miscellaneous), paediatrics, complementary medicine, clinical genetics, clinical biochemistry, transplantation, surgery, infectious disease, nephrology, pulmonology, epidemiology, otolaryngology and anaesthesiology. Being a positive relative contribution speciality in KSA was not influenced by the nature of speciality or by having its own Saudi journal; however, it was associated with a significantly higher KSA ranking based on total documents, total cites and h-index but not based on citations per document. Conclusions: Medical speciality contribution to research productivity in KSA was not influenced by the speciality having a Saudi journal. Positive relative contribution specialities had a significant impact on KSA ranking in three out of the four indices. KSA's medical specialities were ranked relatively low based on citations per document. KSA researchers of all medical disciplines should be encouraged to publish quality research in local and international journals.
{"title":"Medical speciality research in Saudi Arabia: A bibliometric assessment of productivity and worldwide ranking","authors":"A. Jamjoom","doi":"10.4103/2468-6360.198795","DOIUrl":"https://doi.org/10.4103/2468-6360.198795","url":null,"abstract":"Objectives: The objective of this study was to identify the medical specialities that had a positive relative contribution to scientific productivity in the Kingdom of Saudi Arabia (KSA) over the last two decades and to determine the influence of their contribution on KSA worldwide ranking in these specialities. Methods: SCImago Journal and Country Rank was used to determine KSA's ranking in 46 medical specialities during 1996-2014 based on four productivity indices. Relative Specialisation Index (RSI) was calculated for each speciality. Specialities with RSI >0 were defined as the positive relative contribution specialities in KSA. They were compared with the remaining specialities using a number of parameters that were examined statistically. Results: The median KSA ranking in 46 specialities was 42 for total documents, 43 for total cites, 79 for citations per document and 44 for h-index. Fourteen (30%) specialities were designated as the positive relative contribution specialities in KSA. These were ophthalmology, medicine (miscellaneous), paediatrics, complementary medicine, clinical genetics, clinical biochemistry, transplantation, surgery, infectious disease, nephrology, pulmonology, epidemiology, otolaryngology and anaesthesiology. Being a positive relative contribution speciality in KSA was not influenced by the nature of speciality or by having its own Saudi journal; however, it was associated with a significantly higher KSA ranking based on total documents, total cites and h-index but not based on citations per document. Conclusions: Medical speciality contribution to research productivity in KSA was not influenced by the speciality having a Saudi journal. Positive relative contribution specialities had a significant impact on KSA ranking in three out of the four indices. KSA's medical specialities were ranked relatively low based on citations per document. KSA researchers of all medical disciplines should be encouraged to publish quality research in local and international journals.","PeriodicalId":31033,"journal":{"name":"Journal of Health Specialties","volume":"5 1","pages":"23 - 29"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81639206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-01-01DOI: 10.4103/2468-6360.198802
S. Huddart, M. Nash, Aya Abdelrasoul, Inna Bacearnicova, Kyla Bourque, L. Mishra
Patent law flexibilities outlined in the Trade-related Aspects of Intellectual Property Rights agreement make it possible for low-income nations to provide affordable essential medicine during health crises. During the rise of the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) epidemic in South Africa, multinational pharmaceutical companies challenged the implementation of these flexibilities. In response to this lawsuit, the World Trade Organization enacted the Doha Declaration, an affirmation of the right of low-income nations to import and produce generic versions of patented essential medicines. This case study assesses the Doha Declaration's impact on access to HIV/AIDS treatment in South Africa by examining drug pricing, antiretroviral treatment coverage and drug licensing fees. The declaration ultimately contributed to the decrease in HIV/AIDS treatment costs and the subsequent increase in availability and affordability of life-saving drug regimens.
{"title":"The Doha declaration in action: An examination of patent law flexibilities in the South African acquired immunodeficiency syndrome epidemic","authors":"S. Huddart, M. Nash, Aya Abdelrasoul, Inna Bacearnicova, Kyla Bourque, L. Mishra","doi":"10.4103/2468-6360.198802","DOIUrl":"https://doi.org/10.4103/2468-6360.198802","url":null,"abstract":"Patent law flexibilities outlined in the Trade-related Aspects of Intellectual Property Rights agreement make it possible for low-income nations to provide affordable essential medicine during health crises. During the rise of the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) epidemic in South Africa, multinational pharmaceutical companies challenged the implementation of these flexibilities. In response to this lawsuit, the World Trade Organization enacted the Doha Declaration, an affirmation of the right of low-income nations to import and produce generic versions of patented essential medicines. This case study assesses the Doha Declaration's impact on access to HIV/AIDS treatment in South Africa by examining drug pricing, antiretroviral treatment coverage and drug licensing fees. The declaration ultimately contributed to the decrease in HIV/AIDS treatment costs and the subsequent increase in availability and affordability of life-saving drug regimens.","PeriodicalId":31033,"journal":{"name":"Journal of Health Specialties","volume":"3 1","pages":"30 - 34"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83681275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-01-01DOI: 10.4103/2468-6360.198800
Z. Nasr, Fatemeh Jalali, D. Ahmed, K. Wilby
Sodium-glucose cotransporter - 2 (SGLT2) inhibitors are a novel class of anti-diabetics proven to reduce blood pressure, blood glucose and body weight. However, the long-term cardiovascular (CV) safety implications of these agents remain unclear. This systematic review aimed to evaluate the available clinical trial evidence pertaining to long-term cardiovascular safety of SGLT2 inhibitors. The databases EMBASE and MEDLINE were searched. Randomized controlled trials assessing CV safety of SGLT2 inhibitors compared with placebo or anti-diabetic medications were included. Two investigators independently extracted study data and completed risk of bias assessments (sequence generation, allocation concealment, blinding, incomplete outcome data, or selective outcome reporting and other biases). Outcomes included CV death, myocardial infarction, and stroke. A total of 464 studies were identified in the electronic search and 14 from other sources. Sixteen randomized clinical trials were included after full-text review. All studies reported at least one of the pre-defined outcomes (CV death, myocardial infarction, and stroke). Nineteen CV deaths were reported in SGLT2 inhibitors groups versus 10 CV deaths in placebo or other comparator arms; numerically higher in the dapagliflozin arms. The number of CV events was numerically higher in SGLT2 inhibitor groups than in other arms. Risk of bias assessment showed mixed results, with overall quality assessments deemed unclear for 6 of 16 studies (37.5%). Findings showed CV outcomes do occur in patients taking SGLT2 inhibitors yet the clinical significance remains unclear. These results can be considered hypothesis generating, as studies were limited by inadequate power and/or follow-up time. Future longitudinal studies are needed to further assess the efficacy and safety profiles of these new agents before they become widely adopted in clinical practice.
{"title":"Sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes in type 2 diabetes mellitus: A systematic review","authors":"Z. Nasr, Fatemeh Jalali, D. Ahmed, K. Wilby","doi":"10.4103/2468-6360.198800","DOIUrl":"https://doi.org/10.4103/2468-6360.198800","url":null,"abstract":"Sodium-glucose cotransporter - 2 (SGLT2) inhibitors are a novel class of anti-diabetics proven to reduce blood pressure, blood glucose and body weight. However, the long-term cardiovascular (CV) safety implications of these agents remain unclear. This systematic review aimed to evaluate the available clinical trial evidence pertaining to long-term cardiovascular safety of SGLT2 inhibitors. The databases EMBASE and MEDLINE were searched. Randomized controlled trials assessing CV safety of SGLT2 inhibitors compared with placebo or anti-diabetic medications were included. Two investigators independently extracted study data and completed risk of bias assessments (sequence generation, allocation concealment, blinding, incomplete outcome data, or selective outcome reporting and other biases). Outcomes included CV death, myocardial infarction, and stroke. A total of 464 studies were identified in the electronic search and 14 from other sources. Sixteen randomized clinical trials were included after full-text review. All studies reported at least one of the pre-defined outcomes (CV death, myocardial infarction, and stroke). Nineteen CV deaths were reported in SGLT2 inhibitors groups versus 10 CV deaths in placebo or other comparator arms; numerically higher in the dapagliflozin arms. The number of CV events was numerically higher in SGLT2 inhibitor groups than in other arms. Risk of bias assessment showed mixed results, with overall quality assessments deemed unclear for 6 of 16 studies (37.5%). Findings showed CV outcomes do occur in patients taking SGLT2 inhibitors yet the clinical significance remains unclear. These results can be considered hypothesis generating, as studies were limited by inadequate power and/or follow-up time. Future longitudinal studies are needed to further assess the efficacy and safety profiles of these new agents before they become widely adopted in clinical practice.","PeriodicalId":31033,"journal":{"name":"Journal of Health Specialties","volume":"27 1","pages":"16 - 22"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79050626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-01-01DOI: 10.4103/2468-6360.198798
A. Omer, Mohhamed Elnibras Abdularhim
{"title":"The criteria of constructive feedback: The feedback that counts","authors":"A. Omer, Mohhamed Elnibras Abdularhim","doi":"10.4103/2468-6360.198798","DOIUrl":"https://doi.org/10.4103/2468-6360.198798","url":null,"abstract":"","PeriodicalId":31033,"journal":{"name":"Journal of Health Specialties","volume":"87 1","pages":"45 - 48"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76052154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-01-01DOI: 10.4103/2468-6360.198803
F. Munshi, Abdullah H. Alnemari, H. Al-Jifree, A. Alshehri
Objective structured clinical examination (OSCE) has been considered a standard assessment method since its introduction; and as with every assessment tool, OSCE has its advantages and disadvantages. To have OSCE as a reliable method to evaluate examinees, its standards must be set according to certain criteria. Standard setting is one of the methods developed to set the expected pass or fail cut score in an OSCE station. This review article is based on multiple studies that have been proposed to evaluate the reliability and validity of OSCE. There is no single method that is considered best for all testing situations. The choice of a method will depend on what kind of judgements you can get and how much the experience they have in the standing method. All methods of standard setting mentioned are required for judgement. All the standard methods were considered subjective methods. Yet once a standard method has been set, the decisions based on that method can be made objectively. Instead of a separate set of judgements for each applicant, we would get the same set of judgements applied to all applicants. Standards cannot be objectively determined, but they can be objectively applied.
{"title":"Standard setting in objective structured clinical examination: Assigning a pass/fail cut score","authors":"F. Munshi, Abdullah H. Alnemari, H. Al-Jifree, A. Alshehri","doi":"10.4103/2468-6360.198803","DOIUrl":"https://doi.org/10.4103/2468-6360.198803","url":null,"abstract":"Objective structured clinical examination (OSCE) has been considered a standard assessment method since its introduction; and as with every assessment tool, OSCE has its advantages and disadvantages. To have OSCE as a reliable method to evaluate examinees, its standards must be set according to certain criteria. Standard setting is one of the methods developed to set the expected pass or fail cut score in an OSCE station. This review article is based on multiple studies that have been proposed to evaluate the reliability and validity of OSCE. There is no single method that is considered best for all testing situations. The choice of a method will depend on what kind of judgements you can get and how much the experience they have in the standing method. All methods of standard setting mentioned are required for judgement. All the standard methods were considered subjective methods. Yet once a standard method has been set, the decisions based on that method can be made objectively. Instead of a separate set of judgements for each applicant, we would get the same set of judgements applied to all applicants. Standards cannot be objectively determined, but they can be objectively applied.","PeriodicalId":31033,"journal":{"name":"Journal of Health Specialties","volume":"1 1","pages":"8 - 11"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83127242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-01-01DOI: 10.4103/2468-6360.198794
M. Bodrick, F. Munshi
{"title":"Nursing millennials and digitalisation: A call for early leadership development!","authors":"M. Bodrick, F. Munshi","doi":"10.4103/2468-6360.198794","DOIUrl":"https://doi.org/10.4103/2468-6360.198794","url":null,"abstract":"","PeriodicalId":31033,"journal":{"name":"Journal of Health Specialties","volume":"80 1","pages":"1 - 1"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81590024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-01-01DOI: 10.4103/2468-6360.198796
R. Steffen
In the post-World War II period, modern travel medicine was created as an interdisciplinary field not limited to tropical medicine and infectious diseases, but including also dive and high-altitude physiology, geriatrics, public health, etc. The goal is to keep future travellers alive and healthy, and to provide returning travellers with illness or sequelae of accidents the best possible care. With respect to both mortality and morbidity, we now have a broad idea about what is frequent, what in contrast is rare. However, particularly, the World Health Organization requests that more quality data should be generated to assure a safe evidence base for preventive recommendations. The lack of consensus on a global scale is the illustration that even 'experts' so far do not agree on all measures, be they advise immunisation or medication. A further challenge is that we are living in a constantly changing world. Hygienic conditions have improved in some locations, particularly such frequently visited by tourists and businessmen and women; also some infections are being eliminated or reduced by international efforts. On the other hand, new threats are emerging - infectious and other. Thus, in the coming decades, we must create an improved database. We must continue to be vigilant based on coordinated surveillance and we must continue to spread the news to both the travelling public and those health professionals advising them pre-departure, also those in charge of diagnosis and treatment in those returning ill or with injuries.
{"title":"Travel health - Travel medicine","authors":"R. Steffen","doi":"10.4103/2468-6360.198796","DOIUrl":"https://doi.org/10.4103/2468-6360.198796","url":null,"abstract":"In the post-World War II period, modern travel medicine was created as an interdisciplinary field not limited to tropical medicine and infectious diseases, but including also dive and high-altitude physiology, geriatrics, public health, etc. The goal is to keep future travellers alive and healthy, and to provide returning travellers with illness or sequelae of accidents the best possible care. With respect to both mortality and morbidity, we now have a broad idea about what is frequent, what in contrast is rare. However, particularly, the World Health Organization requests that more quality data should be generated to assure a safe evidence base for preventive recommendations. The lack of consensus on a global scale is the illustration that even 'experts' so far do not agree on all measures, be they advise immunisation or medication. A further challenge is that we are living in a constantly changing world. Hygienic conditions have improved in some locations, particularly such frequently visited by tourists and businessmen and women; also some infections are being eliminated or reduced by international efforts. On the other hand, new threats are emerging - infectious and other. Thus, in the coming decades, we must create an improved database. We must continue to be vigilant based on coordinated surveillance and we must continue to spread the news to both the travelling public and those health professionals advising them pre-departure, also those in charge of diagnosis and treatment in those returning ill or with injuries.","PeriodicalId":31033,"journal":{"name":"Journal of Health Specialties","volume":"24 5 1","pages":"42 - 44"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74513169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-01-01DOI: 10.4103/2468-6360.198799
H. Alsanawi
Numerous surgical interventions have been reported for the treatment of Kienbock's disease. However, there is no consensus on the appropriate surgical interventions for the different stages of Kienbock's disease. The present review aims to evaluate and summarise the various surgical interventions and their outcomes in Kienbock's disease. Various electronic databases were searched to identify articles related to surgical interventions. Based on the stage of disease, various surgical options are available that can provide a successful outcome. These surgical procedures include proximal row carpectomy, total wrist arthrodesis, scapho-trapezio-trapezoid arthrodesis, excisional arthroplasty, vascularised bone grafting (VBG), radial shortening osteotomy, radial corrective osteotomy, capitate shortening osteotomy combined with or without VBG and tendon ball arthroplasty and are commonly utilised. Majority of surgical procedures had shown good results in selected patients with advanced Kienbock's disease. In this review, the surgical interventions at an early and late stage of Kienbock's disease will be discussed.
{"title":"Surgical interventions for Kienbock's disease: An update","authors":"H. Alsanawi","doi":"10.4103/2468-6360.198799","DOIUrl":"https://doi.org/10.4103/2468-6360.198799","url":null,"abstract":"Numerous surgical interventions have been reported for the treatment of Kienbock's disease. However, there is no consensus on the appropriate surgical interventions for the different stages of Kienbock's disease. The present review aims to evaluate and summarise the various surgical interventions and their outcomes in Kienbock's disease. Various electronic databases were searched to identify articles related to surgical interventions. Based on the stage of disease, various surgical options are available that can provide a successful outcome. These surgical procedures include proximal row carpectomy, total wrist arthrodesis, scapho-trapezio-trapezoid arthrodesis, excisional arthroplasty, vascularised bone grafting (VBG), radial shortening osteotomy, radial corrective osteotomy, capitate shortening osteotomy combined with or without VBG and tendon ball arthroplasty and are commonly utilised. Majority of surgical procedures had shown good results in selected patients with advanced Kienbock's disease. In this review, the surgical interventions at an early and late stage of Kienbock's disease will be discussed.","PeriodicalId":31033,"journal":{"name":"Journal of Health Specialties","volume":"371 3","pages":"12 - 15"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72448386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-01-01DOI: 10.4103/2468-6360.198797
A. Castro, Margherita M. Cinà, Mary Helmer-Smith, C. Vlček, Collins Oghor, Danielle Cazabon
Human papillomavirus (HPV), a sexually transmitted DNA virus that can lead to cervical cancer, is the most common cancer among women in developing regions. More than 270,000 women die per year from cervical cancer globally, and 85% of those deaths occur in developing countries. In the past, many low- and middle-income countries (LMICs) have been unable to afford the implementation of HPV vaccination programmes, resulting in high cervical cancer mortality rates. Gavi, an organisation created to improve worldwide access to vaccines, undertook an initiative that had the goal of decreasing the price of an HPV vaccine to under $5 and increasing access for adolescent girl populations in LMICs. This was done through market shaping, co-financing and implementation support. This case study will present and evaluate Gavi's intervention by assessing targets, investigating cost-effectiveness and identifying strategic challenges.
{"title":"A case study of Gavi'S human papillomavirus vaccine support programme","authors":"A. Castro, Margherita M. Cinà, Mary Helmer-Smith, C. Vlček, Collins Oghor, Danielle Cazabon","doi":"10.4103/2468-6360.198797","DOIUrl":"https://doi.org/10.4103/2468-6360.198797","url":null,"abstract":"Human papillomavirus (HPV), a sexually transmitted DNA virus that can lead to cervical cancer, is the most common cancer among women in developing regions. More than 270,000 women die per year from cervical cancer globally, and 85% of those deaths occur in developing countries. In the past, many low- and middle-income countries (LMICs) have been unable to afford the implementation of HPV vaccination programmes, resulting in high cervical cancer mortality rates. Gavi, an organisation created to improve worldwide access to vaccines, undertook an initiative that had the goal of decreasing the price of an HPV vaccine to under $5 and increasing access for adolescent girl populations in LMICs. This was done through market shaping, co-financing and implementation support. This case study will present and evaluate Gavi's intervention by assessing targets, investigating cost-effectiveness and identifying strategic challenges.","PeriodicalId":31033,"journal":{"name":"Journal of Health Specialties","volume":"07 1","pages":"2 - 7"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88884782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：